Michelle Morrow
9Patents
4h-index
33Co-inventors
53Inventor score
Filing activity: Nov 24, 2010 → Jun 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8779108B2 | Targeted binding agents against B7-H1 | Chemistry; Metallurgy | 161 | Active |
| US9493565B2 | Targeted binding agents against B7-H1 | Chemistry; Metallurgy | 15 | Active |
| US10400039B2 | Targeted binding agents against B7-H1 | Chemistry; Metallurgy | 5 | Active |
| US10457732B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10092645B2 | Methods of treatment with antagonists against PD-1 and PD-L1 in combination with radiation therapy | Chemistry; Metallurgy | 2 | Active |
| US11279759B2 | Bispecific binding proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12252537B2 | Antibody molecules that bind CD137 and OX40 | Chemistry; Metallurgy | 0 | Active |
| USRE49908E1 | Bispecific binding proteins and uses thereof | General | 0 | Active |
| US11518809B2 | Targeted binding agents against B7-H1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.